Dietary choline and cognition: a favorable association, not proof of protection

What the researchers pooled

This systematic review examines the link between dietary choline intake and several cognitive outcomes, including cognitive decline, mild cognitive impairment and Alzheimer’s disease. It includes eleven articles. Nine independent cohorts, totaling 218,378 participants, contribute to the main analysis.

The researchers pooled estimates using a random-effects model and examined the relationship between the amount consumed and cognitive outcomes. The abstract does not specify follow-up durations, participants’ ages or the exact thresholds used to compare high and low intakes.

A favorable association, but not for every outcome

Higher dietary intakes are associated with an odds ratio of 0.76 across adverse cognitive outcomes, with a 95% confidence interval of 0.63 to 0.92. This measure compares statistical odds: it does not mean that each person would reduce their risk by 24% by increasing their intake.

The association is also statistically significant for cognitive impairment or decline, as well as for Alzheimer’s disease. However, the association with dementia is not statistically significant. The results therefore do not support a blanket promise of prevention.

The abstract does not provide absolute event frequencies. Based on this information alone, the association cannot be translated into a number of cases prevented.

The observed range is not a target dose

The dose-response analysis suggests a nonlinear relationship, with the lowest risks around 350 to 400 mg of dietary choline per day. This does not indicate a relationship in which more is consistently better.

This range remains a statistical observation, not an optimal dose established by a trial. It cannot be used to set an individual intake target for preventing cognitive impairment or to recommend a supplement: the exposure studied is dietary choline.

A plausible mechanism does not demonstrate a benefit

Choline is a precursor to acetylcholine and plays a role in methylation and membrane integrity. These functions make the biological hypothesis plausible, but do not prove that increasing intake slows cognitive decline.

Dietary or health factors associated with choline consumption could contribute to the results. Without the full text, the statistical adjustments, heterogeneity and study quality cannot be examined in detail.

What we can take away

This review strengthens a line of research on dietary choline and cognition. It demonstrates neither a preventive effect nor a benefit from supplementation.